Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

B E Lewis

Showing results (31-40 of 58) with videos related to

Pageof 6
Sort By:
Chest|September 1, 1995
Patency of cryopreserved saphenous vein grafts as conduits for coronary artery bypass surgeryR A Iaffaldano, B E Lewis, S A Johnson, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Inadequacy of current prevention strategies for heparin-induced thrombocytopeniaD E Wallis, B E Lewis, H L Messmore, et al.
Catheterization and Cardiovascular Diagnosis|June 1, 1996
Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndromeB E Lewis, R Iaffaldano, T L McKiernan, et al.
Seminars in Hematology|February 4, 1999
Laboratory tests for heparin-induced thrombocytopenia: a multicenter studyJ M Walenga, W P Jeske, J J Wood, et al.
Medical Care|April 1, 1998
Patient noncompliance in the managed care setting. The case of medical therapy for glaucomaJ H Gurwitz, S M Yeomans, R J Glynn, et al.
The American Journal of Medicine|June 23, 1999
Failure of early heparin cessation as treatment for heparin-induced thrombocytopeniaD E Wallis, D L Workman, B E Lewis, et al.
Catheterization and Cardiovascular Diagnosis|November 1, 1994
Restenosis presented with unstable angina and myocardial infarction: one explanation for late cardiac events following directional coronary atherectomyM H Hwang, B E Lewis, A Hsieh, et al.
Seminars in Hematology|February 4, 1999
Antithrombin agents as anticoagulants and antithrombotics: implications in drug developmentJ Fareed, D Callas, D A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Antithrombin agents: the new class of anticoagulant and antithrombotic drugsJ Fareed, B E Lewis, D D Callas, et al.
International Angiology : a Journal of the International Union of Angiology|February 25, 2000
Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using high performance liquid chromatography and functional methodsS Ahmad, O Iqbal, A Ahsan, et al.
Pageof 6

Showing results (31-40 of 58) with videos related to

Sort By:
Pageof 6
Chest|September 1, 1995
Patency of cryopreserved saphenous vein grafts as conduits for coronary artery bypass surgeryR A Iaffaldano, B E Lewis, S A Johnson, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Inadequacy of current prevention strategies for heparin-induced thrombocytopeniaD E Wallis, B E Lewis, H L Messmore, et al.
Catheterization and Cardiovascular Diagnosis|June 1, 1996
Report of successful use of argatroban as an alternative anticoagulant during coronary stent implantation in a patient with heparin-induced thrombocytopenia and thrombosis syndromeB E Lewis, R Iaffaldano, T L McKiernan, et al.
Seminars in Hematology|February 4, 1999
Laboratory tests for heparin-induced thrombocytopenia: a multicenter studyJ M Walenga, W P Jeske, J J Wood, et al.
Medical Care|April 1, 1998
Patient noncompliance in the managed care setting. The case of medical therapy for glaucomaJ H Gurwitz, S M Yeomans, R J Glynn, et al.
The American Journal of Medicine|June 23, 1999
Failure of early heparin cessation as treatment for heparin-induced thrombocytopeniaD E Wallis, D L Workman, B E Lewis, et al.
Catheterization and Cardiovascular Diagnosis|November 1, 1994
Restenosis presented with unstable angina and myocardial infarction: one explanation for late cardiac events following directional coronary atherectomyM H Hwang, B E Lewis, A Hsieh, et al.
Seminars in Hematology|February 4, 1999
Antithrombin agents as anticoagulants and antithrombotics: implications in drug developmentJ Fareed, D Callas, D A Hoppensteadt, et al.
Clinical and Applied Thrombosis/Hemostasis : Official Journal of the International Academy of Clinical and Applied Thrombosis/Hemostasis|March 22, 2000
Antithrombin agents: the new class of anticoagulant and antithrombotic drugsJ Fareed, B E Lewis, D D Callas, et al.
International Angiology : a Journal of the International Union of Angiology|February 25, 2000
Clinical laboratory monitoring of a synthetic antithrombin agent, argatroban, using high performance liquid chromatography and functional methodsS Ahmad, O Iqbal, A Ahsan, et al.
Pageof 6